Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

Advanced Malignant Solid Tumor

Interventions

BIOLOGICAL

IDOV-SAFE

Intravenous administration of oncolytic virus every 3 weeks until tumor progression

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER